Drug Metabolite

Drug Metabolite

Drug metabolites are created when a drug is metabolized into a different form that still has therapeutic effects. Active metabolites can be produced by drug metabolism redox reactions like heteroatom dealkylations, hydroxylations, heteroatom oxygenations, reductions, and dehydrogenations. In some rare circumstances, conjugation reactions can also produce an active metabolite. 

Drug Metabolite related products

Structure Cat No. Product Name CAS No. Product Description
V72163 Pseudoerythromycin A enol ether (LY267108) 105882-69-7 Pseudoerythromycin A enol ether (LY267108) is a degradation product of erythromycin.
V72151 Quercetin 7-glucuronide (Quercetin 7-O-β-glucuronide) 38934-20-2 Quercetin 7-glucuronide (Quercetin 7-O-β-glucuronide), a metabolite of Quercetin, can be extracted from the Uncarina species in Madagascar.
V72146 Quetiapine sulfoxide hydrochloride (quetiapine sulfoxide hydrochloride; Quetiapine S-oxide hydrochloride) 2448341-72-6 Quetiapine sulfoxide HCl (Quetiapine S-oxide HCl) is the major metabolite of Quetiapinem.
V72248 Radafaxine ((S,S)-Hydroxybupropion; GW-353162A free base; BW-306U free base) 192374-14-4 Radafaxine ((S,S)-Hydroxybupropion) is an antidepressant compound.
V70587 Ramelteon metabolite M-II-d3 1246812-22-5 Ramelteon metabolite M-II-d3 is the deuterium labelled form of Ramelteon metabolite M-II.
V69537 Regorarafénib N-oxyde-d3(M2) (Regorafénib N-oxide (M2 metabolite) impurity 13-d3) 1333489-03-4 Regorafénib N-oxyde-d3(M2) is the deuterated form of Regorafénib N-oxyde M2.
V72175 Resveratrol-3-O-sulfate sodium 858127-11-4 Resveratrol-3-O-sulfate (sodium) is a metabolite of Resveratrol.
V72276 Ritalinic acid (Ritalinic acid; Ritalinate) 19395-41-6 Ritalinic acid (Ritalinate) is the major inactive urinary metabolite of Methylphenidate.
V72213 Rosuvastatin lactone 503610-43-3 Rosuvastatin lactone is a metabolite of rosuvastatin, an HMG-CoA inhibitor.
V72157 RP101075 1306760-73-5 RP101075, the bioactive metabolite of Ozanimod, is a potent oral S1PR1 agonist/activator with EC50 of 0.27 nM.
V72241 RP101442 1306761-08-9 RP101442, the bioactive metabolite of Ozanimod, is a selective S1PR1 agonist/activator with EC50s of 2.6 nM and 171 nM for S1PR1 and S1PR5, respectively.
V76549 RP101988 RP101442 is the main bioactive metabolite of Ozanimod and a selective S1PR1 agonist/activator with EC50s of 0.19 nM and 32.8 nM for S1PR1 and S1P5R respectively.
V76548 RPR132595A hydrochloride (NPC hydrochloride) RPR132595A (NPC) HCl is the bioactive metabolite of CPT-11, which is produced by cytochrome P-450 3A4 (CYP3A4) and is ultimately excreted in the urine.
V72172 S-Allylmercapturic acid 23127-41-5 S-Allylmercapturic acid is a biomarker of garlic consumption food intake (BFI).
V72298 Seco Rapamycin (Secorapamycin; Secorapamycin A) 147438-27-5 Seco Rapamycin (Secorapamycin A) is the open-ring metabolite of Rapamycin.
V76525 Seco Rapamycin ethyl ester Seco Rapamycin ethyl ester is the open-ring metabolite of Rapamycin.
V76496 Sofosbuvir impurity B (sofosbuvir impurity B) Sofosbuvir impurity B is an impurity in Sofosbuvir.
V76495 Sofosbuvir impurity D Sofosbuvir impurity D is an impurity in Sofosbuvir.
V76494 Sofosbuvir impurity E (sofosbuvir impurity E) Sofosbuvir impurity E is an impurity in Sofosbuvir.
V72199 T-705RMP 356783-08-9 T-705RMP is the phosphorylated metabolite of T-705 and has a weak inhibitory effect on host cell IMP dehydrogenase (IMPDH) activity, with IC50 of 601 μM.
Contact Us Back to top